ArticleLancet (London, England)2008
Emergence and control of infectious diseases in China.
Article in Lancet (London, England), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 240 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
240 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Short-Term Exposure to Ambient Air Pollution and Influenza: A Multicity Study in China.Environmental health perspectives · 2023Pooled it
- Small-scale spatiotemporal epidemiology of notifiable infectious diseases in China: a systematic review.BMC infectious diseases · 2022Pooled it
- Infectious diarrheal disease caused by contaminated well water in Chinese schools: A systematic review and meta-analysis.Journal of epidemiology · 2017Pooled it
- Malaria outbreaks in China (1990-2013): a systematic review.Malaria journal · 2014Pooled it
- Incremental Effectiveness of a Second Varicella Vaccine in Children: A Prospective Cohort Study in Anhui, China.Vaccines · 2026Article
- One health perspectives on the epidemiological features and changing incidence of natural focus and vector-borne infectious diseases in China: An observational trend study.One health (Amsterdam, Netherlands) · 2026Article
- The impact of herbal medicine development on the population health in China.Scientific reports · 2026Article
- Age-Period-Cohort analysis of gonorrhea surveillance data in Eastern China from 2005 to 2024.BMC infectious diseases · 2026Article
- Rural revitalization, carbon emissions, and infectious disease transmission in China: nonlinear dynamics, spatial spillovers, and moderating effect.Frontiers in public health · 2026Article
- Economic evaluation of including the EV71 vaccine in the national immunization program: a modeling study in Guangxi, China.Frontiers in public health · 2026Article
- Spatial-temporal patterns, seasonality, and age-specific trends of varicella in Hangzhou, China, 2019-2024.Frontiers in public health · 2026Article
- Epidemiological trends of reported syphilis incidence in Xihu district, Hangzhou, China, 2005-2025.Frontiers in epidemiology · 2026Article
- The changing epidemiology of syphilis: new strategies for new challenges in China.The Lancet regional health. Western Pacific · 2025Review
- A narrative review on the effectiveness of PPSV23 vaccination in adults in China.Human vaccines & immunotherapeutics · 2025Review
- Wildfire-related PM2.5 and respiratory transmitted disease among Chinese children and adolescents from 2008 to 2019: A retrospective study.PLoS medicine · 2025Article
- Comparative Performance of Wastewater, Clinical, and Digital Surveillance Indicators for COVID-19 Monitoring in Routine Practice: Retrospective Observational Study.Journal of medical Internet research · 2025Observational
- Epidemiological analysis of infectious diseases in older people in China from 2014 to 2022: a population-based study.The Lancet regional health. Western Pacific · 2025Article
- Enhancing regional disease burden estimates: insights from the comparison of Global Burden of Disease and China's notifiable infectious diseases data with policy implications (2010-2020).Infectious diseases of poverty · 2025Article
- A Spatial analysis of chickenpox in Chongqing, China, during 2015-2023.Scientific reports · 2025Article
- Subnational Evidence for the Attributable Burden of Respiratory Infections in China's Population under 20: Challenges from Particulate Matter Pollution.Environment & health (Washington, D.C.) · 2025Article
180 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
7 authors.
Funding
Abstract
Infectious diseases remain the major causes of morbidity and mortality in China despite substantial progress in their control. China is a major contributor to the worldwide infectious disease burden because of its population size. The association of China with the rest of the world through travel and trade means that events in the country can affect distant populations. The ecological interaction of people with animals in China favours the emergence of new microbial threats. The public-health system has to be prepared to deal with the challenges of newly emerging infectious diseases and at the same time try to control existing diseases. To address the microbial threats, such as severe acute respiratory syndrome, the government has committed substantial resources to the implementation of new strategies, including the development of a real-time monitoring system as part of the infectious-disease surveillance. This strategy can serve as a model for worldwide surveillance and response to threats from infectious diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.